Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Tzourio Christophe) "

Sökning: WFRF:(Tzourio Christophe)

  • Resultat 11-15 av 15
  • Föregående 1[2]
Sortera/gruppera träfflistan
  • Peters, Ruth, et al. (författare)
  • An investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis.
  • 2020
  • Ingår i: Neurology. - 1526-632X. ; 94:3, s. e267-e281
  • Tidskriftsartikel (refereegranskat)abstract
    • High blood pressure is one of the main modifiable risk factors for dementia. However, there is conflicting evidence regarding the best antihypertensive class for optimizing cognition. Our objective was to determine whether any particular antihypertensive class was associated with a reduced risk of cognitive decline or dementia using comprehensive meta-analysis including reanalysis of original participant data.To identify suitable studies, MEDLINE, Embase, and PsycINFO and preexisting study consortia were searched from inception to December 2017. Authors of prospective longitudinal human studies or trials of antihypertensives were contacted for data sharing and collaboration. Outcome measures were incident dementia or incident cognitive decline (classified using the reliable change index method). Data were separated into mid and late-life (>65 years) and each antihypertensive class was compared to no treatment and to treatment with other antihypertensives. Meta-analysis was used to synthesize data.Over 50,000 participants from 27 studies were included. Among those aged >65 years, with the exception of diuretics, we found no relationship by class with incident cognitive decline or dementia. Diuretic use was suggestive of benefit in some analyses but results were not consistent across follow-up time, comparator group, and outcome. Limited data precluded meaningful analyses in those ≤65 years of age.Our findings, drawn from the current evidence base, support clinical freedom in the selection of antihypertensive regimens to achieve blood pressure goals.The review was registered with the international prospective register of systematic reviews (PROSPERO), registration number CRD42016045454.
  • Rådholm, Karin, et al. (författare)
  • Older age is a strong predictor for poor outcome in intracerebral haemorrhage : the INTERACT2 study
  • 2015
  • Ingår i: Age and Ageing. - : Oxford University Press. - 0002-0729 .- 1468-2834. ; 44:3, s. 422-427
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND AND PURPOSE:: Global ageing contributes greatly to the burden of stroke. We investigated the influence of age on the baseline profile and on outcomes in acute intracerebral haemorrhage (ICH) among participants of the INTERACT2 study.METHODS:: INTERACT2 was an international, randomised controlled trial in 2839 patients with spontaneous ICH within 6 h of onset and elevated systolic blood pressure (SBP; 150-220 mmHg) who were allocated to receive intensive (target SBP <140 mmHg within 1 h) or guideline-recommended (target SBP <180 mmHg) blood pressure lowering treatment. Stroke severity was assessed with the National Institutes of Health Stroke Scale. Poor outcome was defined as death or major disability ('dependency', modified Rankin Scale scores 3-6) at 90 days. Health-related quality of life (HRQoL) was assessed with the European Quality of Life-5 Dimensions (EQ-5D) questionnaire. Associations between age and outcomes were analysed in multivariable logistic regression models.RESULTS:: Stroke severity increased in categories of older age (P-trend 0.002). Stroke patients over 75 years old were four times more likely to die or be disabled at 90 days than those <52 years when other confounders were accounted for (odds ratio 4.36, 95% confidence interval 3.12-6.08). Older age was also associated with decreasing HRQoL, across mobility, self-care, usual activities and depression (all P-trend <0.001), and pain or discomfort (P-trend 0.022).CONCLUSION:: In the INTERACT2 cohort, older people had more severe ICH and worse outcomes (death, major disability and HRQoL). These data will help guide clinicians manage older people with haemorrhagic stroke. Clinical Trial Registration: http://www.clinicaltrials.gov (NCT00716079).
  • Satizabal, Claudia L., et al. (författare)
  • Genetic architecture of subcortical brain structures in 38,851 individuals
  • 2019
  • Ingår i: Nature Genetics. - : Nature Publishing Group. - 1061-4036 .- 1546-1718. ; 51:11, s. 1624-
  • Tidskriftsartikel (refereegranskat)abstract
    • Subcortical brain structures are integral to motion, consciousness, emotions and learning. We identified common genetic variation related to the volumes of the nucleus accumbens, amygdala, brainstem, caudate nucleus, globus pallidus, putamen and thalamus, using genome-wide association analyses in almost 40,000 individuals from CHARGE, ENIGMA and UK Biobank. We show that variability in subcortical volumes is heritable, and identify 48 significantly associated loci (40 novel at the time of analysis). Annotation of these loci by utilizing gene expression, methylation and neuropathological data identified 199 genes putatively implicated in neurodevelopment, synaptic signaling, axonal transport, apoptosis, inflammation/infection and susceptibility to neurological disorders. This set of genes is significantly enriched for Drosophila orthologs associated with neurodevelopmental phenotypes, suggesting evolutionarily conserved mechanisms. Our findings uncover novel biology and potential drug targets underlying brain development and disease.
  • van Rheenen, Wouter, et al. (författare)
  • Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
  • 2016
  • Ingår i: Nature Genetics. - 1061-4036 .- 1546-1718. ; 48:9, s. 1043-1048
  • Tidskriftsartikel (refereegranskat)abstract
    • To elucidate the genetic architecture of amyotrophic lateral sclerosis (ALS) and find associated loci, we assembled a custom imputation reference panel from whole-genome-sequenced patients with ALS and matched controls (n = 1,861). Through imputation and mixed-model association analysis in 12,577 cases and 23,475 controls, combined with 2,579 cases and 2,767 controls in an independent replication cohort, we fine-mapped a new risk locus on chromosome 21 and identified C21orf2 as a gene associated with ALS risk. In addition, we identified MOBP and SCFD1 as new associated risk loci. We established evidence of ALS being a complex genetic trait with a polygenic architecture. Furthermore, we estimated the SNP-based heritability at 8.5%, with a distinct and important role for low-frequency variants (frequency 1-10%). This study motivates the interrogation of larger samples with full genome coverage to identify rare causal variants that underpin ALS risk.
  • Wain, Louise V., et al. (författare)
  • Novel Blood Pressure Locus and Gene Discovery Using Genome-Wide Association Study and Expression Data Sets From Blood and the Kidney
  • 2017
  • Ingår i: Hypertension. - 0194-911X .- 1524-4563. ; 70:3, s. e4-e19
  • Tidskriftsartikel (refereegranskat)abstract
    • Elevated blood pressure is a major risk factor for cardiovascular disease and has a substantial genetic contribution. Genetic variation influencing blood pressure has the potential to identify new pharmacological targets for the treatment of hypertension. To discover additional novel blood pressure loci, we used 1000 Genomes Project-based imputation in 150 134 European ancestry individuals and sought significant evidence for independent replication in a further 228 245 individuals. We report 6 new signals of association in or near HSPB7, TNXB, LRP12, LOC283335, SEPT9, and AKT2, and provide new replication evidence for a further 2 signals in EBF2 and NFKBIA. Combining large whole-blood gene expression resources totaling 12 607 individuals, we investigated all novel and previously reported signals and identified 48 genes with evidence for involvement in blood pressure regulation that are significant in multiple resources. Three novel kidney-specific signals were also detected. These robustly implicated genes may provide new leads for therapeutic innovation.
Skapa referenser, mejla, bekava och länka
  • Resultat 11-15 av 15
  • Föregående 1[2]
Typ av publikation
tidskriftsartikel (14)
forskningsöversikt (1)
Typ av innehåll
refereegranskat (15)
Tzourio, Christophe (15)
Amouyel, Philippe (11)
Hofman, Albert (11)
Gudnason, Vilmundur (9)
Schmidt, Reinhold (8)
Amin, Najaf (7)
visa fler...
Bis, Joshua C. (7)
Smith, Albert V. (7)
Psaty, Bruce M. (7)
Rotter, Jerome I. (7)
Van Duijn, Cornelia ... (7)
Seshadri, Sudha (6)
Cheng, Ching -Yu (6)
Uitterlinden, Andre ... (6)
Trompet, Stella (5)
Chauhan, Ganesh (5)
Hofer, Edith (5)
Liewald, David C. M. (5)
Milaneschi, Yuri (5)
Teumer, Alexander (5)
Bennett, David A. (5)
Boomsma, Dorret I. (5)
De Jager, Philip L. (5)
Foroud, Tatiana M. (5)
Hardy, John (5)
Hartman, Catharina A ... (5)
Hottenga, Jouke-Jan (5)
Lopez, Oscar L. (5)
Lovestone, Simon (5)
Mecocci, Patrizia (5)
Noethen, Markus M. (5)
Penninx, Brenda W. J ... (5)
Deary, Ian J. (5)
Tsolaki, Magda (4)
Salomaa, Veikko (4)
Chouraki, Vincent (4)
Lopez, Lorna M. (4)
Van Eijk, Kristel R. (4)
Brodaty, Henry (4)
Cichon, Sven (4)
DeStefano, Anita L. (4)
Jukema, J. Wouter (4)
Mosley, Thomas H. (4)
Ophoff, Roel A. (4)
Rietschel, Marcella (4)
Sachdev, Perminder S ... (4)
Stott, David J. (4)
Vardarajan, Badri N. (4)
Vernooij, Meike W. (4)
Wardlaw, Joanna M. (4)
visa färre...
Uppsala universitet (10)
Umeå universitet (5)
Stockholms universitet (4)
Göteborgs universitet (2)
Lunds universitet (2)
Linköpings universitet (1)
visa fler...
Karolinska Institutet (1)
visa färre...
Engelska (15)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (14)
Naturvetenskap (2)


Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy